LIMINATUS PHARMA INC. - CLASS A COMMON STOCK

3.4100

22-August-25 13:45:00

15 minutes delayed

Stocks

+0.6300

+22.66%

Today's range

3.0900 - 4.0600

ISIN

N/A

Source

NASDAQ

Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative

28 Jul 2025 04:30:00 By Nasdaq GlobeNewswire
Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment Vehicle Targeting Up To $500 Million in Capital Strategies

25 Jul 2025 05:31:58 By Nasdaq GlobeNewswire
Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy

24 Jul 2025 05:31:00 By Nasdaq GlobeNewswire
Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy

22 Jul 2025 10:30:00 By Nasdaq GlobeNewswire

<<
<
1
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.